MEDINDIA
English
हिन्दी
Español
français
中文
Dexamethasone – a steroid used significantly to reduce COVID-19 mortality, may be less effective in patients with diabetes.
Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.
TOP INSIGHT
Dexamethasone may be less effective in COVID-19 patients, having diabetes. A blood protein, called serum albumin binds with dexamethasone to transport them throughout the body. High blood sugars modify the way albumin binds with dexamethasone and hence, reduces the drug efficacy.
The research team led by scientists at the University of Virginia, used powerful X-rays from the APS to get a full picture of the structure of serum albumin combined with dexamethasone, with aid of remote access technology. These findings re-emphasize the ways, physicians prescribe the drug for certain patients.
"Gaining new insight into the mechanisms of this drug will help doctors design more effective treatments," said Argonne's Bob Fischetti, life sciences advisor to the APS director. “Since the start of this pandemic, the APS has been a powerful tool for gaining insights into the virus itself, and into methods for combating it."
Type 2 Diabetes - Risk Factors - Symptoms & Signs - Management - Prevention
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of the World.
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of the World.
Dexamethasone Use for COVID-19 Treatment
The Union Ministry of Health and Family Welfare has released an updated clinical management protocol for managing COVID-19 cases, advising use of dexamethasone as an alternative to methylprednisolone for managing moderate to severe cases of the disease.
The Union Ministry of Health and Family Welfare has released an updated clinical management protocol for managing COVID-19 cases, advising use of dexamethasone as an alternative to methylprednisolone for managing moderate to severe cases of the disease.
WHO Welcomes Results of Dexamethasone Against COVID-19
The World Health Organization (WHO) welcomed the positive results of dexamethasone in treating the novel coronavirus, while warning that the drug should not be used on mild cases.
The World Health Organization (WHO) welcomed the positive results of dexamethasone in treating the novel coronavirus, while warning that the drug should not be used on mild cases.
Email
